Prevalence of presumptive clinical signs of breast cancer among women attending an early detection campaign in Lomé in 2023 [0.03%]
2023年洛美乳房癌症疑似临床症状的流行率（一项早期检测活动中的女性）
Adjovi Evenunye Sodokin,Kokoe Melinda Gbadoe,Adanvo Isaac Houngnigbe et al.
Adjovi Evenunye Sodokin et al.
Introduction: breast cancer is the most common cancer in women in Togo. Screening and early diagnosis campaigns are organised to limit the late use of health services. The aim of this study was to determine the prevalence...
Multicenter Study
The Pan African medical journal. 2025 Apr 9:50:98. DOI:10.11604/pamj.2025.50.98.43237 2025
Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications [0.03%]
乳腺癌中细胞角蛋白的表达：从机制、进展、诊断和预后到治疗意义
Ensiyeh Bahadoran,Sahar Moghbelinejad,Ghazaleh Mohammadi et al.
Ensiyeh Bahadoran et al.
Background and aim: Cytokeratins (CKs) are structural proteins vital to epithelial integrity and play key roles in breast cancer progression. This review explores their expression, functions, and therapeutic potential. ...
"Mourning Parts You Dreamed of Losing-But Not This Way": The Experience of a Nonbinary Person Diagnosed With Breast Cancer [0.03%]
“至爱的部分是你在梦中失去的——但不是这种方式”：一位被诊断出乳腺癌的非二元性别者的心路历程
Sara Cho,Mike Hooves,Claire Temple-Oberle
Sara Cho
Purpose: Nonbinary breast cancer (NBBC) patients have unique healthcare needs that may not be met due to the gendered nature of breast cancer. Herein we explore the multifaceted experiences of an NBBC person. Methods: Qualitative intensive ...
Effects of exercise interventions on bone health and body composition in postmenopausal women with breast cancer: a systematic review and meta-analysis [0.03%]
锻炼对乳腺癌绝经后妇女骨健康和身体成分的影响：系统评价和荟萃分析
Shan Yu,Chengfei Gao,Chuanjian Yi et al.
Shan Yu et al.
Objective: To evaluate the effects of exercise interventions on bone health and body composition in postmenopausal women with breast cancer. Methods: ...
Advances in breast cancer diagnosis: a comprehensive review of imaging, biosensors, and emerging wearable technologies [0.03%]
乳腺癌诊断进展：成像、生物传感器及新兴可穿戴技术的全面综述
Abdul Qadeer Khan,Manahil Touseeq,Sara Rehman et al.
Abdul Qadeer Khan et al.
Breast cancer has been the most frequent diagnosed cancer and the leading cause of cancer-related deaths among women worldwide, mainly due to delayed detection. Early diagnosis significantly improves prognosis and long-term survival rates. ...
Uptake of breast cancer screening methods: perspectives of members of staff of Federal Medical Centre, Abeokuta [0.03%]
尼日尔利亚阿约布卡特联邦医疗中心工作人员对乳腺癌筛查方法的看法
Jessica O Esangbedo,Rachael O Oduyemi,Damilare Aduroja et al.
Jessica O Esangbedo et al.
Introduction: Breast cancer (BC) was ranked the most common among the top ten malignancies in 2022, evidenced by high incidence and rates rapid mortality and morbidity rates in Nigeria. BC screening method (BCSM) helps to...
Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in India [0.03%]
印度三级医疗中心年轻女性de novo转移性乳腺癌的临床特征及转归：真实世界数据
Sushmita Rath,Mehak Trikha,Laboni Sarkar et al.
Sushmita Rath et al.
Background: Denovo metastatic young breast cancer (dnmYBC), defined as age
Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study [0.03%]
他莫昔芬与来曲唑治疗中国绝经前激素受体阳性乳腺癌的非劣性 randomized phase 3 tedinya study
Wei Bai,Liying Peng,Yinli Gui et al.
Wei Bai et al.
Background and objectives: No prior studies have directly compared sirolimus with the standard of care (SoC) for lupus nephritis (LN) patients. This study aimed to compare the efficacy and safety of sirolimus with mycophe...
Disparities in Breast Cancer-related Lymphedema: A Systematic Review of Inequities and Barriers in Care [0.03%]
乳腺癌相关淋巴水肿的差异：护理不公平和障碍的系统评价
Alexzandra Mattia,Nina Hadzimustafic,Rachel Rivero et al.
Alexzandra Mattia et al.
Background: Breast cancer-related lymphedema (BCRL) is a chronic condition secondary to multimodal cancer treatment. This systematic review summarized the evidence for disparities and barriers surrounding BCRL care, parti...
Mechanistic study of N-acetyltransferase 10 deficiency enhancing olaparib sensitivity in triple negative breast cancer by inhibiting RAD51 N4-acetylcytidine modification [0.03%]
N-乙酰转移酶10缺乏通过抑制RAD51 N4-乙酰胞苷修饰增强PARP抑制剂敏感性研究
Hui Li,Hao Wu,Siwei Li et al.
Hui Li et al.
The treatment of triple-negative breast cancer (TNBC) is challenging due to the lack of common treatment targets, making standard hormonal and targeted therapies ineffective. While PARP inhibitors are promising for TNBC, they are only effec...
耗时 0.34126 秒，为您在
48322673
条记录里面共找到 10000 篇文章 [XML]